The Enterprise Value as of December 2025 (TTM) for Unicycive Therapeutics, Inc. (UNCY) is 72.37M

According to Unicycive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 72.37M. This represents a change of 94.18% compared to the average of 37.27M of the last 4 quarters.

Unicycive Therapeutics, Inc. (UNCY) Historical Enterprise Value (quarterly & annually)

How has UNCY Enterprise Value performed in the past?

The mean historical Enterprise Value of Unicycive Therapeutics, Inc. over the last ten years is 31.14M. The current 72.37M Enterprise Value has changed 23.14% with respect to the historical average. Over the past ten years (40 quarters), UNCY's Enterprise Value was at its highest in in the March 2021 quarter at 432.16M. The Enterprise Value was at its lowest in in the June 2024 quarter at -20672002.60.

Unicycive Therapeutics, Inc. (UNCY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Unicycive Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unicycive Therapeutics, Inc. (UNCY) Average Enterprise Value

How has UNCY Enterprise Value performed in the past?

The current Enterprise Value of Unicycive Therapeutics, Inc. (UNCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Unicycive Therapeutics, Inc. (UNCY) Enterprise Value vs. Peers

How is UNCY’s Enterprise Value compared to its peers?

Unicycive Therapeutics, Inc.’s Enterprise Value is greater than CAMP4 Therapeutics Corporation (40.08M), less than Vaxart, Inc. (87.39M), greater than Repare Therapeutics Inc. (23.36M), greater than Biomea Fusion, Inc. (31.03M), greater than Immunic, Inc. (32.92M), greater than Acrivon Therapeutics, Inc. Common Stock (43.63M), greater than PMV Pharmaceuticals, Inc. (25.00M), less than Relmada Therapeutics, Inc. (291.98M), less than MindWalk Holdings Corp. (132.03M), less than Cibus, Inc. (94.92M),

Build a custom stock screener for Unicycive Therapeutics, Inc. (UNCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unicycive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unicycive Therapeutics, Inc. (UNCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unicycive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.